AI-Mind closes World Alzheimer’s Month with a look ahead to key October events

September is globally recognised as World Alzheimer’s Month, a time to raise awareness, challenge stigma and highlight progress in dementia research and care. Throughout the month, AI-Mind partners actively contributed to local initiatives across Europe, engaging with clinicians, policymakers and the public to share knowledge about early detection and the potential of artificial intelligence (AI) in supporting brain health.

As September comes to a close, the AI-Mind consortium is preparing for a dynamic October, with participation in several high-profile events. These occasions will bring the project’s innovations to international audiences and foster dialogue on how AI can support dementia prevention and care. Highlights include a featured AI-Mind session at the Alzheimer Europe Conference, representation at the Brain Innovation Days in Brussels and a Cambridge Cognition webinar on digital tools and biomarkers.

AI-Mind at the 35th Alzheimer Europe Conference

8 October, 14:00-15:15, Bologna Congress Centre

The Alzheimer Europe Conference (AEC) is one of the most important annual gatherings for dementia research, care, and policy. At the 35th edition in Bologna, AI-Mind will host a featured session entitled:

“AI-Mind at the Finnish Line: Advancing Trustworthy and Scalable Clinical AI for Early Dementia Risk Detection.”

As the project approaches its conclusion, this session will showcase key outcomes and strategic insights from four years of European collaboration dedicated to developing AI-driven tools for the early detection of dementia. Drawing on the AI-Mind cohort and the broader ambitions of the EURO-TWIN initiative, the session will explore how AI can be responsibly and effectively embedded within clinical and regulatory frameworks.

More information at Alzheimer Europe Conference 2025.

The programme will include four thematic contributions:

Key figures and clinical implementation insights: presented by Christoffer Hatlestad-Hall (Oslo University Hospital, Norway), highlighting results from the AI-Mind study and lessons from deploying the AI-Mind protocol.
Technological transformation: Lukas Gemein (Oslo University Hospital, Norway) will demonstrate the potential of AI in cognitive healthcare and its integration into clinical workflows.
Regulatory readiness: Tim Govers (The Radboud University Medical Center, the Netherlands) will discuss alignment with European regulatory standards and the importance of transparency, accountability, and compliance.
Real-world clinical adoption: Guido Giuffrè (Università Cattolica del Sacro Cuore, Italy)  will provide a practitioner’s perspective on the relevance of AI-Mind solutions in hospitals and local communities, emphasising cross-sector collaboration.

Moderated by Ira Haraldsen, the AI-Mind coordinator, the session will conclude with a forward-looking discussion on how initiatives like EURO-TWIN can build on AI-Mind’s achievements, scaling towards next-generation, personalised virtual health twin technologies to support stratified interventions for cognitive decline.

The session will be recorded, and the video will be made available on the AI-Mind YouTube channel. Visitors can also find there the recording from AI-Mind’s session at the 33rd Alzheimer Europe Conference (Helsinki, 2023), dedicated to “The Potential of Artificial Intelligence for Dementia Risk Prediction.”

Brain Innovation Days

15-16 October 2025, Brussels, Belgium

Just a week after the AEC, AI-Mind will be present at the Brain Innovation Days, organised by the European Brain Council. Project coordinator Ira Haraldsen will represent AI-Mind in discussions on the benefits and impact of artificial intelligence in brain health research and care.

At the European Health and Digital Executive Agency booth, visitors can also find project flyers and an AI-Mind supplement to Dementia in Europe Magazine, highlighting the project’s work. Vebjørn Anderson from Oslo University Hospital will be on site to discuss AI-Mind’s approach and answer questions from stakeholders.

Focusing on The Adaptive Brain in a Fast-Evolving World, this year’s sessions will revolve around the following subthemes:

Brain Research Frontiers: Driving Europe’s Innovation Leadership
Brain Health Equity: Closing the Gap to Leave No One Behind
Youth Culture: Shaping Brain Health in the Modern World
Beyond Neuroscience: Reimagining the World Through a Brain Health Lens

Cambridge Cognition Webinar

29 October 2025, 16:00–17:00, online

Closing off the month, AI-Mind will take part in a webinar organised by Cambridge Cognition on “Integrating Blood-Based Biomarker Tests & Digital Cognitive Assessments to Accelerate Brain Health Research.” Advances in blood-based biomarker tests (BBMs) offer more accessible and cost-effective diagnostics in Alzheimer’s disease. When strategically combined with sensitive digital cognitive assessments (DCAs), they can provide a multi-dimensional view of brain health, connecting biological pathology with real-world functional outcomes. AI-Mind will be represented by Christoffer Hatlestad-Hall, specialising in electrophysiology and cognitive neuroscience, sharing insights on leveraging multimodal data: EEG, blood-based biomarkers, cognitive and clinical assessments and AI methods to improve understanding of dementia risk in patients with mild cognitive decline. His contribution to the discussion underlines the consortium’s commitment to advancing innovative solutions for brain health.

Looking ahead

With these events, AI-Mind continues to strengthen its presence in the European research and innovation landscape. By engaging with diverse stakeholders, from clinicians and scientists to policymakers and patient groups, the project is advancing dialogue on the potential of AI to transform dementia risk prediction and improve quality of life.

Stay tuned to the AI-Mind News & Events page for updates, event reports and opportunities to get involved.